Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Human papillomavirus"" wg kryterium: Temat


Tytuł :
Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.
Autorzy :
Mboumba Bouassa RS; Laboratoire de virologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Ecole Doctorale Régionale en Infectiologie Tropicale, Franceville, Gabon.; Université Paris Descartes, Paris Sorbonne Cité, Paris, France.; INSERM UMR_S970, Immunothérapie et traitement anti-angiogénique en cancérologie, Paris Centre de Recherche Cardiovasculaire (PARCC), hôpital européen Georges Pompidou, AP-HP, Paris, France.
Péré H; Laboratoire de virologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Université Paris Descartes, Paris Sorbonne Cité, Paris, France.; INSERM UMR_S970, Immunothérapie et traitement anti-angiogénique en cancérologie, Paris Centre de Recherche Cardiovasculaire (PARCC), hôpital européen Georges Pompidou, AP-HP, Paris, France.
Gubavu C; Service des maladies infectieuses et tropicales, Centre hospitalier régional d'Orléans and Centre Gratuit d'Information, de Dépistage et de Diagnostic (CEGIDD) d'Orléans, Orléans, France.
Prazuck T; Service des maladies infectieuses et tropicales, Centre hospitalier régional d'Orléans and Centre Gratuit d'Information, de Dépistage et de Diagnostic (CEGIDD) d'Orléans, Orléans, France.
Jenabian MA; Département des Sciences Biologiques et Centre de Recherche BioMed, Université du Québec à Montréal (UQAM), Montreal, Quebec, Canada.
Veyer D; Laboratoire de virologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Meye JF; Service de Gynécologie Obstétrique, Centre Hospitalo-Universitaire d'Agondjé et Faculté de Médecine de Libreville, Université des Sciences de la Santé, Libreville, Gabon.
Touzé A; UMRINRA ISP 1282, Equipe Biologie des infections à polyomavirus, Université de Tours, Tours, France.
Bélec L; Laboratoire de virologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Ecole Doctorale Régionale en Infectiologie Tropicale, Franceville, Gabon.; Université Paris Descartes, Paris Sorbonne Cité, Paris, France.; INSERM UMR_S970, Immunothérapie et traitement anti-angiogénique en cancérologie, Paris Centre de Recherche Cardiovasculaire (PARCC), hôpital européen Georges Pompidou, AP-HP, Paris, France.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 May 18; Vol. 15 (5), pp. e0233084. Date of Electronic Publication: 2020 May 18 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Viral/*metabolism
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/*immunology
Papillomavirus Infections/*diagnosis
Uterine Cervical Neoplasms/*virology
Adult ; Africa South of the Sahara/ethnology ; Antibodies, Viral/blood ; Cervix Uteri/immunology ; Early Detection of Cancer ; Emigrants and Immigrants/statistics & numerical data ; Female ; France/ethnology ; Human papillomavirus 16/immunology ; Human papillomavirus 18/immunology ; Humans ; Middle Aged ; Papillomavirus Infections/immunology ; Uterine Cervical Neoplasms/immunology ; Vagina/immunology
Czasopismo naukowe
Tytuł :
Antiviral activity of curcumin-nanoemulsion associated with photodynamic therapy in vulvar cell lines transducing different variants of HPV-16.
Autorzy :
Bonfim CMD; Laboratory of Genomic Studies, Sao Paulo State University - UNESP, São Paulo, Brazil.
Monteleoni LF; Laboratory of Genomic Studies, Sao Paulo State University - UNESP, São Paulo, Brazil.
Calmon MF; Laboratory of Genomic Studies, Sao Paulo State University - UNESP, São Paulo, Brazil.
Cândido NM; Laboratory of Genomic Studies, Sao Paulo State University - UNESP, São Paulo, Brazil.
Provazzi PJS; Laboratory of Genomic Studies, Sao Paulo State University - UNESP, São Paulo, Brazil.
Lino VS; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo - USP, São Paulo, Brazil.
Rabachini T; Institute of Pharmacology, University of Bern, Bern, Switzerland.
Sichero L; ICESP, Center for Translational Research in Oncology- Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil.
Villa LL; ICESP, Center for Translational Research in Oncology- Instituto do Cancer do Estado de Sao Paulo, São Paulo, Brazil.; Departament of Radiology and Oncology, School of Medicine, Universidade de Sao Paulo - USP, São Paulo, Brazil.
Quintana SM; Department of Gynecology and Obstetrics of the Ribeirão Preto Medical School, USP, Ribeirão Preto, São Paulo, Brazil.
Melli PPDS; Department of Gynecology and Obstetrics of the Ribeirão Preto Medical School, USP, Ribeirão Preto, São Paulo, Brazil.
Primo FL; Department of Bioprocess and Biotechnology, Faculty of Pharmaceutical Sciences of Araraquara, Universidade Estadual Paulista Julio de Mesquita Filho - UNESP, Araraquara, São Paulo, Brazil.
Amantino CF; Department of Chemistry, Center for Nanotechnology and Tissue Engineering, Faculty of Philosophy, Sciences and Languages ​​of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil.
Tedesco AC; Department of Chemistry, Center for Nanotechnology and Tissue Engineering, Faculty of Philosophy, Sciences and Languages ​​of Ribeirão Preto, University of São Paulo - USP, Ribeirão Preto, São Paulo, Brazil.
Boccardo E; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo - USP, São Paulo, Brazil.
Rahal P; Laboratory of Genomic Studies, Sao Paulo State University - UNESP, São Paulo, Brazil.
Pokaż więcej
Źródło :
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2020 Dec; Vol. 48 (1), pp. 515-524.
Typ publikacji :
Journal Article
MeSH Terms :
Antiviral Agents/*pharmacology
Curcumin/*pharmacology
Human papillomavirus 16/*drug effects
Photosensitizing Agents/*pharmacology
Adult ; Carcinoma in Situ/virology ; Cell Line, Tumor ; Cell Survival/drug effects ; Cell Survival/radiation effects ; Curcumin/chemistry ; Emulsions ; Female ; Genotype ; Human papillomavirus 16/genetics ; Human papillomavirus 16/isolation & purification ; Humans ; Light ; Nanoparticles/chemistry ; Oncogene Proteins, Viral/genetics ; Papillomavirus Infections/virology ; Repressor Proteins/genetics ; Vulvar Neoplasms/virology
Czasopismo naukowe
Tytuł :
Internally controlled recombinase-aided amplification (IC-RAA) assays for the detection of human papillomavirus genotypes 16 and 18 using extracted DNA and samples treated with nucleic acid releasing agent.
Autorzy :
Wang J; Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050031, Hebei, China.; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.; Myasthenia Gravis Research Institute, The First Hospital of Shijiazhuang, 36 Fanxi Road, Shijiazhuang, 050011, Hebei, China.
Liu J; General Administration of Customs (Beijing) International Travel Healthcare Centre, No. 20 Heping Li North Street, Dongcheng District, Beijing, 100013, China.
Song G; Myasthenia Gravis Research Institute, The First Hospital of Shijiazhuang, 36 Fanxi Road, Shijiazhuang, 050011, Hebei, China.
Cao Z; Beijing Chaoyang Maternal and Child Health Hospital, No. 25 Huaweili, Chaoyang District, Beijing, China.
Pan J; Myasthenia Gravis Research Institute, The First Hospital of Shijiazhuang, 36 Fanxi Road, Shijiazhuang, 050011, Hebei, China.
Li X; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Gao Y; Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050031, Hebei, China.; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Qi J; Myasthenia Gravis Research Institute, The First Hospital of Shijiazhuang, 36 Fanxi Road, Shijiazhuang, 050011, Hebei, China.
Chen Z; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Fan G; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Bai X; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Zhang R; Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050031, Hebei, China.; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Wang R; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Duan Q; Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050031, Hebei, China.; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China.
Li L; Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050031, Hebei, China. .; Myasthenia Gravis Research Institute, The First Hospital of Shijiazhuang, 36 Fanxi Road, Shijiazhuang, 050011, Hebei, China. .
Shen X; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China. .
Ma X; NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Street, Changping District, Beijing, 102206, China. .
Pokaż więcej
Źródło :
Archives of virology [Arch Virol] 2020 Oct; Vol. 165 (10), pp. 2241-2247. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Journal Article
MeSH Terms :
Nucleic Acid Amplification Techniques*
DNA, Viral/*genetics
Human papillomavirus 16/*genetics
Human papillomavirus 18/*genetics
Papillomavirus Infections/*diagnosis
Uterine Cervical Neoplasms/*diagnosis
Adolescent ; Adult ; Aged ; Cervix Uteri/pathology ; Cervix Uteri/virology ; DNA Primers/chemical synthesis ; DNA Primers/genetics ; Epithelial Cells/pathology ; Epithelial Cells/virology ; Female ; Human papillomavirus 16/classification ; Human papillomavirus 16/isolation & purification ; Human papillomavirus 18/classification ; Human papillomavirus 18/isolation & purification ; Humans ; Middle Aged ; Papillomavirus Infections/pathology ; Papillomavirus Infections/virology ; Reagent Kits, Diagnostic ; Sensitivity and Specificity ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
Tytuł :
Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features.
Autorzy :
Gutnik H; Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia. .
Kastelic P; Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Oštrbenk Valenčak A; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška cesta 4, 1000, Ljubljana, Slovenia.
Poljak M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloška cesta 4, 1000, Ljubljana, Slovenia.
Strojan Fležar M; Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000, Ljubljana, Slovenia.
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Feb; Vol. 476 (2), pp. 251-260. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji :
Journal Article
MeSH Terms :
Cervical Intraepithelial Neoplasia/*pathology
Cervical Intraepithelial Neoplasia/*virology
Human papillomavirus 16/*pathogenicity
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*pathology
Early Detection of Cancer/methods ; Female ; Human papillomavirus 18/pathogenicity ; Humans ; Papillomaviridae/pathogenicity ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/pathology ; Squamous Intraepithelial Lesions/pathology ; Squamous Intraepithelial Lesions/virology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
Tytuł :
Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.
Autorzy :
da Silva RL; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
da Silva Batista Z; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
Bastos GR; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
Cunha APA; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
Figueiredo FV; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
de Castro LO; Faculty of Medicine, Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
Dos Anjos Pereira L; Faculty of Medicine, Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
da Silva MACN; Faculty of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.
Vidal FCB; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
Barros MC; Center of Advanced Studies of Caxias (CESC), State University of Maranhão (UEMA), Caxias, Maranhão, Brazil.
da Costa Fraga E; Center of Advanced Studies of Caxias (CESC), State University of Maranhão (UEMA), Caxias, Maranhão, Brazil.
Brito LMO; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
do Carmo Lacerda Barbosa M; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil.
Moreira MÂM; Genetic Division, National Institute of Cancer (INCA), Rio de Janeiro, Brazil.
do Desterro Soares Brandão Nascimento M; Federal University of Maranhão (UFMA), São Luís, Maranhão, Brazil. .
Pokaż więcej
Źródło :
BMC women's health [BMC Womens Health] 2020 Aug 01; Vol. 20 (1), pp. 162. Date of Electronic Publication: 2020 Aug 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA, Viral/*genetics
Human papillomavirus 16/*genetics
Human papillomavirus 16/*isolation & purification
Papillomaviridae/*genetics
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*virology
Adult ; Aged ; Aged, 80 and over ; Brazil/epidemiology ; Female ; Genetic Variation ; Human papillomavirus 16/classification ; Humans ; Middle Aged ; Papillomaviridae/classification ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/pathology ; Polymerase Chain Reaction ; Prospective Studies ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł :
HPV Vaccination and the Risk of Invasive Cervical Cancer.
Autorzy :
Lei J; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Ploner A; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Elfström KM; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Wang J; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Roth A; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Fang F; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Sundström K; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Dillner J; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Sparén P; From the Departments of Medical Epidemiology and Biostatistics (J.L., A.P., P.S.) and Laboratory Medicine (K.M.E., J.W., K.S., J.D.) and the Institute of Environmental Medicine (F.F.), Karolinska Institutet, the Regional Cancer Center Stockholm Gotland (K.M.E.), and the Karolinska University Laboratory, Karolinska University Hospital (J.D.), Stockholm, the Department of Communicable Disease Control and Health Protection, Public Health Agency of Sweden, Solna (A.R.), and the Department of Translational Medicine, Lund University, Lund (A.R.) - all in Sweden.
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Oct 01; Vol. 383 (14), pp. 1340-1348.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18*
Uterine Cervical Neoplasms/*prevention & control
Adolescent ; Adult ; Child ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Immunization Programs ; Incidence ; Neoplasm Invasiveness ; Registries ; Sweden/epidemiology ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/pathology ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
Autorzy :
Fogelberg S; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Clements MS; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pedersen K; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Sy S; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Sparén P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Kim JJ; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Burger EA; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 30; Vol. 15 (9), pp. e0239611. Date of Electronic Publication: 2020 Sep 30 (Print Publication: 2020).
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cost-Benefit Analysis*
Early Detection of Cancer/*economics
Human Papillomavirus DNA Tests/*economics
Uterine Cervical Neoplasms/*diagnosis
Adult ; Early Detection of Cancer/standards ; Female ; Human Papillomavirus DNA Tests/standards ; Humans ; Sensitivity and Specificity ; Sweden ; Uterine Cervical Neoplasms/prevention & control ; Uterine Cervical Neoplasms/virology ; Vaccination/statistics & numerical data
Czasopismo naukowe
Tytuł :
Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Autorzy :
Zheng Y; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Jönsson J; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Hao C; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Shoja Chaghervand S; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Cui X; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Kajitani N; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Gong L; China Institute of Sport and Health Sciences, Beijing Sport University, Beijing, Haidian District, China.
Wu C; Department of Laboratory Medicine, Lund University, Lund, Sweden .; The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong Province, China.; Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Province, China.
Schwartz S; Department of Laboratory Medicine, Lund University, Lund, Sweden .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Sep 29; Vol. 94 (20). Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
RNA Splicing*
Heterogeneous Nuclear Ribonucleoprotein A1/*metabolism
Heterogeneous-Nuclear Ribonucleoprotein Group A-B/*metabolism
Human papillomavirus 16/*metabolism
Papillomavirus E7 Proteins/*metabolism
RNA, Viral/*metabolism
HeLa Cells ; Heterogeneous Nuclear Ribonucleoprotein A1/genetics ; Heterogeneous-Nuclear Ribonucleoprotein Group A-B/genetics ; Human papillomavirus 16/genetics ; Humans ; Oncogene Proteins, Viral/genetics ; Oncogene Proteins, Viral/metabolism ; Papillomavirus E7 Proteins/genetics ; RNA, Viral/genetics ; Repressor Proteins/genetics ; Repressor Proteins/metabolism
Czasopismo naukowe
Tytuł :
The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.
Autorzy :
Lou H; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Boland JF; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Torres-Gonzalez E; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Albanez A; Instituto de Cancerologia, Guatemala City, Guatemala.
Zhou W; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Steinberg MK; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Diaw L; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Mitchell J; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Roberson D; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Cullen M; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Garland L; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Bass S; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Burk RD; Departments of Pediatrics, Microbiology and Immunology, and Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York.
Yeager M; Cancer Genetics Research Laboratory, Division of Cancer Epidemiology and Genetics, Leidos Biomedical Research Inc., National Laboratory for Cancer Research, Gaithersburg, Maryland.
Wentzensen N; Laboratory of Cancer Genetics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Schiffman M; Laboratory of Cancer Genetics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Freites EA; Hospital Central Universitario 'Dr. Antonio M Pineda,' Barquisimeto, Lara State, Venezuela.; Universidad Andina del Cusco, Vicerrectorado de Investigación, Division of Cancer Research, Cusco, Perú.
Gharzouzi E; Integra Cancer Institute, Guatemala City, Guatemala.
Mirabello L; Laboratory of Cancer Genetics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland.
Dean M; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, Gaithersburg, Maryland. .
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Sep 15; Vol. 80 (18), pp. 3803-3809. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :
Adenocarcinoma/*genetics
Human papillomavirus 16/*genetics
Interferon Regulatory Factors/*genetics
Papillomavirus Infections/*genetics
Uterine Cervical Neoplasms/*genetics
Virus Integration/*genetics
Adenocarcinoma/virology ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Class I Phosphatidylinositol 3-Kinases/genetics ; DNA, Viral/analysis ; DNA, Viral/genetics ; Female ; Genome, Viral ; Guatemala ; Human papillomavirus 16/classification ; Humans ; Middle Aged ; Mutation ; Papillomavirus Infections/complications ; Papillomavirus Infections/virology ; Precancerous Conditions/complications ; Precancerous Conditions/genetics ; Precancerous Conditions/virology ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
Tytuł :
HPV16 induces penile intraepithelial neoplasia and squamous cell carcinoma in transgenic mice: first mouse model for HPV-related penile cancer.
Autorzy :
Medeiros-Fonseca B; CITAB, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.
Mestre VF; CITAB, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.
Estêvão D; Grupo de Oncologia Molecular e Patologia Viral, CI-IPOP, IPO-Porto, Porto, Portugal.; Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Sánchez DF; Instituto de Patología e Investigación and Universidad Nacional de Asunción, Asunción, Paraguay.
Cañete-Portillo S; Instituto de Patología e Investigación and Universidad Nacional de Asunción, Asunción, Paraguay.
Fernández-Nestosa MJ; Instituto de Patología e Investigación and Universidad Nacional de Asunción, Asunción, Paraguay.
Casaca F; Botelho Moniz Análises Clínicas (BMAC), Porto, Portugal.
Silva S; Botelho Moniz Análises Clínicas (BMAC), Porto, Portugal.
Brito H; Biobanco de Tumores e DNA do Maranhão, PPGSAD, Universidade Federal do Maranhão (UFMA), São Luís, Brazil.
Félix A; Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.; Serviço de Anatomia Patológica, IPO-Lisboa, Lisbon, Portugal.
Medeiros R; Grupo de Oncologia Molecular e Patologia Viral, CI-IPOP, IPO-Porto, Porto, Portugal.; Faculdade de Medicina, Universidade do Porto, Porto, Portugal.; Serviço de Virologia, IPO-Porto, Porto, Portugal.; Liga Portuguesa Contra o Cancro - Núcleo Regional do Norte, Porto, Portugal.; CEBIMED, Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Porto, Portugal.
Colaço B; CITAB, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.; Departamento de Zootecnia, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.
Oliveira PA; CITAB, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.; Departamento de Ciências Veterinárias, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.
Bastos MM; LEPABE, Faculdade de Engenharia, Universidade do Porto, Porto, Portugal.
Nelson PS; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; University of Washington, Seattle, WA, USA.
Vakar-Lopez F; LEPABE, Faculdade de Engenharia, Universidade do Porto, Porto, Portugal.
Gaivão I; CECAV and Department of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.
Brito L; Biobanco de Tumores e DNA do Maranhão, PPGSAD, Universidade Federal do Maranhão (UFMA), São Luís, Brazil.
Lopes C; Botelho Moniz Análises Clínicas (BMAC), Porto, Portugal.; Grupo de Patologia Experimental, Ci-IPOP, IPO-Porto, Porto, Portugal.; Departamento de Patologia e Imunologia Molecular, ICBAS, Universidade do Porto, Porto, Portugal.
Cubilla AL; Instituto de Patología e Investigación and Universidad Nacional de Asunción, Asunción, Paraguay.
Gil da Costa RM; CITAB, Universidade de Trás-os-Montes e Alto Douro, UTAD, Vila Real, Portugal.; Grupo de Oncologia Molecular e Patologia Viral, CI-IPOP, IPO-Porto, Porto, Portugal.; Biobanco de Tumores e DNA do Maranhão, PPGSAD, Universidade Federal do Maranhão (UFMA), São Luís, Brazil.; LEPABE, Faculdade de Engenharia, Universidade do Porto, Porto, Portugal.; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Pokaż więcej
Źródło :
The Journal of pathology [J Pathol] 2020 Aug; Vol. 251 (4), pp. 411-419.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma in Situ/*virology
Carcinoma, Squamous Cell/*virology
Human papillomavirus 16/*physiology
Papillomavirus Infections/*virology
Penile Neoplasms/*virology
Animals ; Carcinogenesis ; Carcinoma in Situ/pathology ; Carcinoma, Squamous Cell/pathology ; Cell Proliferation ; Disease Models, Animal ; Human papillomavirus 16/genetics ; Humans ; Immunohistochemistry ; Male ; Mice ; Mice, Transgenic ; Oncogene Proteins, Viral/genetics ; Oncogene Proteins, Viral/metabolism ; Papillomavirus E7 Proteins/genetics ; Papillomavirus E7 Proteins/metabolism ; Papillomavirus Infections/pathology ; Penile Neoplasms/pathology ; Penis/pathology ; Penis/virology ; Random Allocation ; Repressor Proteins/genetics ; Repressor Proteins/metabolism
Czasopismo naukowe
Tytuł :
Simultaneous quantification of major capsid protein of human papillomavirus 16 and human papillomavirus 18 in multivalent human papillomavirus vaccines by liquid chromatography-tandem mass spectrometry.
Autorzy :
Ning T; Beijing Key Laboratory for Precancerous Lesion of Digestive Disease, Department of Gastroenterology, Beijing Friendship Hospital, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, Capital Medical University, Beijing, China; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), No.31 Huatuo Street, Daxing District, Beijing.102629, China.
Sun S; Division of Physics and Chemistry, National Institutes for Food and Drug Control (NIFDC), No.2 Tiantanxili, Dongcheng District, Beijing 100050, China.
Nie J; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), No.31 Huatuo Street, Daxing District, Beijing.102629, China.
Li M; Division of Physics and Chemistry, National Institutes for Food and Drug Control (NIFDC), No.2 Tiantanxili, Dongcheng District, Beijing 100050, China.
Huang W; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), No.31 Huatuo Street, Daxing District, Beijing.102629, China.
Li X; Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, Canada.
Cao J; Division of Physics and Chemistry, National Institutes for Food and Drug Control (NIFDC), No.2 Tiantanxili, Dongcheng District, Beijing 100050, China. Electronic address: .
Wang Y; Division of HIV/AIDS and Sexually Transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC), No.31 Huatuo Street, Daxing District, Beijing.102629, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of chromatography. A [J Chromatogr A] 2020 May 24; Vol. 1619, pp. 460962. Date of Electronic Publication: 2020 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Chromatography, Liquid*
Human papillomavirus 16*
Human papillomavirus 18*
Tandem Mass Spectrometry*
Capsid Proteins/*analysis
Papillomavirus Vaccines/*analysis
Antibodies, Viral ; Humans
Czasopismo naukowe
Tytuł :
The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
Autorzy :
Duan L; Department of Gynecology and Obstetrics, Peking University Shenzhen Hospital, Shenzhen, China.; Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecological Diseases, Shenzhen, PR,China.
Du H; Department of Gynecology and Obstetrics, Peking University Shenzhen Hospital, Shenzhen, China.; Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecological Diseases, Shenzhen, PR,China.
Wang C; Department of Gynecology and Obstetrics, Peking University Shenzhen Hospital, Shenzhen, China.; Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecological Diseases, Shenzhen, PR,China.
Huang X; Department of Gynecology and Obstetrics, Peking University Shenzhen Hospital, Shenzhen, China.; Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecological Diseases, Shenzhen, PR,China.
Qu X; Sanming Project of Medicine in Shenzhen Peking University Shenzhen Hospital, Shenzhen, China.
Shi B; Department of Gynecology and Obstetrics, The Second Hospital of Hebei Medical University, Hebei, China.
Liu Y; Department of Gynecology and Obstetrics, Huashan Hospital North, Fudan University, Shanghai, China.
Zhang W; Department of Gynecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, China.
Duan X; Department of Gynecology and Obstetrics, Capital Medical University Beijing Tongren Hospital, Beijing, PR, China.
Wei L; Department of Gynecology and Obstetrics, Peking University People's Hospital, Beijing, PR, China.
Belinson JL; Preventive Oncology International, Cleveland Heights, OH, United States of America.; Women's Health Institute, Cleveland Clinic, Cleveland, OH, United States of America.
Wu R; Department of Gynecology and Obstetrics, Peking University Shenzhen Hospital, Shenzhen, China.; Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecological Diseases, Shenzhen, PR,China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 May 01; Vol. 15 (5), pp. e0232117. Date of Electronic Publication: 2020 May 01 (Print Publication: 2020).
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Viral Load*
Early Detection of Cancer/*methods
Human papillomavirus 16/*isolation & purification
Human papillomavirus 18/*isolation & purification
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*virology
Adult ; Female ; Genotype ; Human papillomavirus 16/genetics ; Human papillomavirus 18/genetics ; Humans ; Middle Aged ; Papillomavirus Infections/diagnosis ; Triage ; Uterine Cervical Neoplasms/diagnosis
Czasopismo naukowe
Tytuł :
Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Autorzy :
Trevisan A; Sainte-Justine Hospital Research Center, Université de Montréal, Montreal, Canada.; Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, Canada.
Candeias JMG; Department of Microbiology and Immunology, Institute of Biosciences, Universidade Estadual Paulista, Botucatu, Brazil.
Thomann P; Ludwig Institute for Cancer Research, Sao Paulo, Brazil.
Villa LL; Dept of Radiology and Oncology, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil.; Instituto do Cancer do Estado de São Paulo, Universidade de São Paulo, Sao Paulo, Brazil.
Franco EL; Division of Cancer Epidemiology, McGill University, Montreal, Canada.
Trottier H; Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montreal, Canada.; Sainte-Justine Hospital Research Center, Université de Montréal, Montreal, Canada.
The Ludwig-McGill Study Group; See acknowledgments for details.
Pokaż więcej
Źródło :
Journal of medical microbiology [J Med Microbiol] 2020 Jul; Vol. 69 (7), pp. 960-970.
Typ publikacji :
Journal Article
MeSH Terms :
Human papillomavirus 16/*genetics
Human papillomavirus 16/*immunology
Papillomavirus Infections/*diagnosis
Adult ; Antibodies, Viral/blood ; Brazil ; Capsid/immunology ; Capsid Proteins/genetics ; Cervix Uteri/virology ; Cohort Studies ; Female ; Human papillomavirus 16/pathogenicity ; Humans ; Leukocyte L1 Antigen Complex/immunology ; Oncogene Proteins, Viral/genetics ; Oncogene Proteins, Viral/immunology ; Papillomaviridae/genetics ; Papillomavirus Infections/genetics ; Papillomavirus Infections/immunology ; Uterine Cervical Neoplasms/etiology ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/virology ; Viral Load/methods ; Virion/immunology
Czasopismo naukowe
Tytuł :
Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas.
Autorzy :
Dalla Libera LS; Universidade Federal de Goiás (UFG), Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Faculdade de Medicina (FM) e Instituto de Patologia Tropical e Saúde Pública (IPTSP), Goiânia, GO, Brasil.
de Siqueira T; Pontifícia Universidade Católica de Goiás (PUC/GO), Programa de Pós-Graduação em Ciências Ambientais e Saúde (MCAS) e Escola de Ciências Médicas, Farmacêuticas e Biomédicas (ECMFB), Goiânia, GO, Brasil.
Santos IL; Pontifícia Universidade Católica de Goiás (PUC/GO), Programa de Pós-Graduação em Ciências Ambientais e Saúde (MCAS) e Escola de Ciências Médicas, Farmacêuticas e Biomédicas (ECMFB), Goiânia, GO, Brasil.
Porto Ramos JE; Pontifícia Universidade Católica de Goiás (PUC/GO), Programa de Pós-Graduação em Ciências Ambientais e Saúde (MCAS) e Escola de Ciências Médicas, Farmacêuticas e Biomédicas (ECMFB), Goiânia, GO, Brasil.
Milhomen AX; Pontifícia Universidade Católica de Goiás (PUC/GO), Programa de Pós-Graduação em Ciências Ambientais e Saúde (MCAS) e Escola de Ciências Médicas, Farmacêuticas e Biomédicas (ECMFB), Goiânia, GO, Brasil.
Alencar RCG; Departamento de Patologia, Hospital Araújo Jorge (HAJ)-Associação de Combate ao Câncer em Goiás (ACCG), Goiânia, GO, Brasil.
Rabelo Santos SH; Universidade Federal de Goiás (UFG), Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Faculdade de Medicina (FM) e Instituto de Patologia Tropical e Saúde Pública (IPTSP), Goiânia, GO, Brasil.
Dos Santos Carneiro MA; Universidade Federal de Goiás (UFG), Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Faculdade de Medicina (FM) e Instituto de Patologia Tropical e Saúde Pública (IPTSP), Goiânia, GO, Brasil.
Figueiredo Alves RR; Universidade Federal de Goiás (UFG), Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Faculdade de Medicina (FM) e Instituto de Patologia Tropical e Saúde Pública (IPTSP), Goiânia, GO, Brasil.
Saddi VA; Universidade Federal de Goiás (UFG), Programa de Pós-Graduação em Ciências da Saúde (PPGCS), Faculdade de Medicina (FM) e Instituto de Patologia Tropical e Saúde Pública (IPTSP), Goiânia, GO, Brasil.; Pontifícia Universidade Católica de Goiás (PUC/GO), Programa de Pós-Graduação em Ciências Ambientais e Saúde (MCAS) e Escola de Ciências Médicas, Farmacêuticas e Biomédicas (ECMFB), Goiânia, GO, Brasil.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Jun 25; Vol. 15 (6), pp. e0235065. Date of Electronic Publication: 2020 Jun 25 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Colorectal Neoplasms*/pathology
Colorectal Neoplasms*/virology
Cyclin-Dependent Kinase Inhibitor p16*/biosynthesis
Cyclin-Dependent Kinase Inhibitor p16*/genetics
Gene Expression Regulation, Neoplastic*
Human papillomavirus 16*/genetics
Human papillomavirus 16*/metabolism
Papillomavirus Infections*/genetics
Papillomavirus Infections*/metabolism
Papillomavirus Infections*/pathology
Adult ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
HPV6 and HPV11 Genome Methylation in Condyloma Accuminatum Measured by Bisulfite Sequencing.
Autorzy :
Wu DD; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, People Republic of China.
Long FQ; STD Institute, Shanghai Skin Disease Hospital, Shanghai, People Republic of China.
Gao J; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, People Republic of China.
Zhong L; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, People Republic of China.; Provincial Demonstration Center for Experimental Biology Education, Shaanxi Normal University, Xi'an, People Republic of China.
Sun C; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, Key Laboratory of the Ministry of Education for Medicinal Resources and Natural Pharmaceutical Chemistry, College of Life Sciences, Shaanxi Normal University, Xi'an, People Republic of China.
Pokaż więcej
Źródło :
The American Journal of dermatopathology [Am J Dermatopathol] 2019 Jul; Vol. 41 (7), pp. 534-535.
Typ publikacji :
Letter
MeSH Terms :
DNA Methylation*
Genome, Viral*
Human Papillomavirus DNA Tests*
Sequence Analysis, DNA*
Buschke-Lowenstein Tumor/*virology
Human papillomavirus 11/*genetics
Human papillomavirus 6/*genetics
CpG Islands ; Humans ; Male ; Pilot Projects
Opinia redakcyjna
Tytuł :
Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
Autorzy :
Tawe L; Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
MacDuffie E; Warren Alpert Medical School of Brown University, Providence, RI.
Narasimhamurthy M; Department of Pathology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Wang Q; Sue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA.
Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.
Moyo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.
Kasvosve I; Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Shin SS; Sue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA.
Zetola NM; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Paganotti GM; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Grover S; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Mar 15; Vol. 146 (6), pp. 1667-1673. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections/*virology
Human papillomavirus 16/*isolation & purification
Human papillomavirus 18/*isolation & purification
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*virology
Anti-HIV Agents/therapeutic use ; Botswana/epidemiology ; Cervix Uteri/pathology ; Cervix Uteri/virology ; Cost of Illness ; Cross-Sectional Studies ; DNA, Viral/genetics ; DNA, Viral/isolation & purification ; Female ; Genotype ; HIV Infections/complications ; HIV Infections/drug therapy ; Human papillomavirus 16/genetics ; Human papillomavirus 18/genetics ; Humans ; Middle Aged ; Papillomavirus Infections/complications ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/prevention & control ; Papillomavirus Vaccines/administration & dosage ; Prevalence ; Retrospective Studies ; Uterine Cervical Neoplasms/complications ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/prevention & control ; Vaccination
Czasopismo naukowe
Tytuł :
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Autorzy :
Cleveland AA; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Gargano JW; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Park IU; Department of Family and Community Medicine, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Griffin MR; Vanderbilt University Medical Center, Nashville, TN, USA.
Niccolai LM; Yale School of Public Health, New Haven, CT, USA.
Powell M; Oregon Department of Human Services, Portland, OR, USA.
Bennett NM; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Saadeh K; California Emerging Infections Program, Oakland, CA, USA.
Pemmaraju M; Vanderbilt University Medical Center, Nashville, TN, USA.
Higgins K; Yale School of Public Health, New Haven, CT, USA.
Ehlers S; Oregon Department of Human Services, Portland, OR, USA.
Scahill M; University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
Johnson Jones ML; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Querec T; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Markowitz LE; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Unger ER; Centers for Disease Control and Prevention, Atlanta, GA, USA.
Pokaż więcej
Corporate Authors :
HPV-IMPACT Working Group
Źródło :
International journal of cancer [Int J Cancer] 2020 Feb 01; Vol. 146 (3), pp. 810-818. Date of Electronic Publication: 2019 May 06.
Typ publikacji :
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Adenocarcinoma in Situ/*epidemiology
Cervical Intraepithelial Neoplasia/*epidemiology
Human papillomavirus 16/*isolation & purification
Human papillomavirus 18/*isolation & purification
Papillomavirus Infections/*epidemiology
Precancerous Conditions/*epidemiology
Adenocarcinoma in Situ/prevention & control ; Adenocarcinoma in Situ/virology ; Adolescent ; Adult ; Age Factors ; Cervical Intraepithelial Neoplasia/prevention & control ; Cervical Intraepithelial Neoplasia/virology ; DNA, Viral/isolation & purification ; Female ; Human papillomavirus 16/genetics ; Human papillomavirus 18/genetics ; Humans ; Incidence ; Mass Screening/statistics & numerical data ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/virology ; Papillomavirus Vaccines/therapeutic use ; Precancerous Conditions/prevention & control ; Precancerous Conditions/virology ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/prevention & control ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Human Papillomavirus 31 Tyrosine 102 Regulates Interaction with E2 Binding Partners and Episomal Maintenance.
Autorzy :
Gilson T; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Culleton S; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Xie F; Department of Dermatology, Chinese People's Liberation Army General Hospital, Beijing, China.
DeSmet M; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Androphy EJ; Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA .; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Jul 30; Vol. 94 (16). Date of Electronic Publication: 2020 Jul 30 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
DNA-Binding Proteins/*metabolism
Human papillomavirus 31/*genetics
Plasmids/*metabolism
Viral Proteins/*metabolism
Cell Line ; DNA Helicases/metabolism ; DNA Replication/physiology ; DNA-Binding Proteins/physiology ; Genome, Viral/genetics ; HEK293 Cells ; Human papillomavirus 31/pathogenicity ; Humans ; Nuclear Proteins/metabolism ; Phosphorylation ; Plasmids/genetics ; Transcription Factors/metabolism ; Tyrosine/genetics ; Viral Proteins/physiology ; Virus Replication/physiology
Czasopismo naukowe
Tytuł :
Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis.
Autorzy :
Bannach C; Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Brinkert P; Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Kühling L; Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany.
Greune L; Institute of Infectiology, ZMBE, University of Münster, Münster, Germany.
Schmidt MA; Institute of Infectiology, ZMBE, University of Münster, Münster, Germany.
Schelhaas M; Institute of Cellular Virology, ZMBE, University of Münster, Münster, Germany .; Cluster of Excellence EXC1003, Cells in Motion, CiM, Münster, Germany.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 May 18; Vol. 94 (11). Date of Electronic Publication: 2020 May 18 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Endocytosis*
Signal Transduction*
Virus Internalization*
Human papillomavirus 16/*metabolism
Protein-Tyrosine Kinases/*metabolism
Animals ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; HeLa Cells ; Human papillomavirus 16/genetics ; Humans ; Mice ; Protein-Tyrosine Kinases/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies